22157.jpg
World Engineering Microorganisms into Powerful Micromachines Market Study 2021: Can Synthetic Biology Foster Bio-Revolution?
December 06, 2021 07:18 ET | Research and Markets
Dublin, Dec. 06, 2021 (GLOBE NEWSWIRE) -- The "Engineering Microorganisms into Powerful Micromachines: Can Synthetic Biology Foster Bio-Revolution??" report has been added to...
22157.jpg
Global Biochips/Microarray Market Research Report 2021 with Focus on Protein Biochips/Microarrays, Microfluidics and Nanobiotechnology-based Nano-arrays
December 01, 2021 04:28 ET | Research and Markets
Dublin, Dec. 01, 2021 (GLOBE NEWSWIRE) -- The "Biochips - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This report is...
logo_Codex_landscape_color_RGB (1).png
Codex DNA Announces Commercial Availability of Automated mRNA Synthesis Kit with Integrated Capping Technology for BioXp™ System
November 29, 2021 08:03 ET | Codex DNA, Inc.
Proven CleanCap® reagent technology from TriLink BioTechnologies delivers significant time and cost savings for mRNA-based vaccine and therapeutic applicationsCodex DNA scientists to share latest data...
Codex DNA and RNAimmune Announce Collaboration to Optimize Development of Future mRNA Synthesis and Delivery Kits
November 22, 2021 08:03 ET | Codex
San Diego, CA, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, and RNAimmune, a leading biotech company with expertise in...
22157.jpg
Global Synthetic Biology Market Report (2021 to 2030) - Featuring Genscript, Integrated DNA Technologies and Amyris Among Others
November 10, 2021 06:43 ET | Research and Markets
Dublin, Nov. 10, 2021 (GLOBE NEWSWIRE) -- The "Synthetic Biology Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. This...
logo_Codex_landscape_color_RGB (1).png
Codex DNA Acquires Eton Bioscience
November 09, 2021 16:15 ET | Codex DNA, Inc.
SAN DIEGO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, announced today that it has agreed to acquire Eton Bioscience,...
logo_Codex_landscape_color_RGB (1).png
Codex DNA Reports Third Quarter 2021 Financial Results
November 09, 2021 16:15 ET | Codex DNA, Inc.
SAN DIEGO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today reported financial results for the third quarter ended...
logo_Codex_landscape_color_RGB (1).png
Codex DNA to Report Third Quarter 2021 Financial Results on Tuesday, November 9, 2021
November 02, 2021 07:00 ET | Codex DNA, Inc.
SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced that it will release its third quarter 2021...
22157.jpg
Insights on the Food Biotechnology Global Market to 2026 - Featuring ABS Global, BASF and Monsanto Among Others
November 02, 2021 05:23 ET | Research and Markets
Dublin, Nov. 02, 2021 (GLOBE NEWSWIRE) -- The "Food Biotechnology Market Research Report by Type, Application, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been...
MEDIA ALERT: Codex DNA Customer to Highlight Advantages of Automated BioXp™ System in Precision Cancer Immunotherapy Applications at 13th Annual PEGS Europe Protein and Antibody Engineering Summit
November 01, 2021 08:03 ET | Codex
San Diego, CA, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced that one of its customers will be...